TerminatedNCT00094120
MSI-1256F (Squalamine Lactate) in Combination With Verteporfin in Patients With "Wet" Age-Related Macular Degeneration (AMD)
PHASE2 · 60 planned enrolment
- Countries listed
- 1
- Registry update
- January 9, 2008
Source-linked trial list
The registrations behind this number.
Verify the exact trial registrations behind a company, intervention, programme or topic count.
Exact trial list
3 matching trial registrations
- Intervention MSI-1256F (Squalamine Lactate)
Showing 1–3 of 3. Every record below meets all the filters shown above.
TerminatedNCT00333476
A Study of MSI-1256F (Squalamine Lactate) To Treat "Wet" Age-Related Macular Degeneration
PHASE2 · 140 planned enrolment
- Countries listed
- 1
- Registry update
- November 28, 2007
TerminatedNCT00089830
A Safety and Efficacy Study of MSI-1256F (Squalamine Lactate) To Treat "Wet" Age-Related Macular Degeneration
PHASE2 · 120 planned enrolment
- Countries listed
- 1
- Registry update
- November 28, 2007